CapsoVision amended its development agreement with Canon covering the development of CMOS image sensor samples for capsule endoscopies. The amendment increased the total fee by USD 1 million due to added specification features. Under the agreement, CapsoVision is to pay an initial USD 1 million in cash and a remaining development fee of about USD 3.1 million after delivery milestones. The remaining development fee is to be paid over time by adding an agreed amount to the unit price of sensors supplied under a planned master purchase agreement.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Capso Vision Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001378325-26-000002), on March 13, 2026, and is solely responsible for the information contained therein.
Comments